Ingevity Corporation carries a market capitalization of 2.31B, placing it among publicly traded companies globally. Its enterprise value stands at 3.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.31B |
| Enterprise Value | 3.71B |
Ingevity Corporation currently has 34.89M shares outstanding.
| Shares Outstanding | 34.89M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 2.11, and the price-to-book ratio stands at 5.50.
| PE Ratio | N/A |
| PS Ratio | 2.11 |
| PB Ratio | 5.50 |
| P/TBV Ratio | -19.19 |
| P/FCF Ratio | 8.51 |
| P/OCF Ratio | 8.42 |
On an enterprise value basis, Ingevity Corporation trades at an EV/EBITDA multiple of 9.74 and an EV/FCF ratio of 9.77. The EV/Sales ratio of 3.06 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.41 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.06 |
| EV / EBITDA | 9.74 |
| EV / EBIT | 13.41 |
| EV / FCF | 9.77 |
Ingevity Corporation maintains a current ratio of 1.42, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3,199.74, indicating elevated leverage, while an interest coverage ratio of 5.19 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.42 |
| Quick Ratio | 0.60 |
| Debt / Equity | 3,199.74 |
| Debt / EBITDA | 3.27 |
| Interest Coverage | 5.19 |
| Return on Equity (ROE) | -24.16 |
| Return on Assets (ROA) | -6.90 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 5.25 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.28 |
Over the trailing twelve months, Ingevity Corporation has paid 5.40M in income taxes, reflecting an effective tax rate of 56.92.
| Income Tax | 5.40M |
| Effective Tax Rate | 56.92 |
Ingevity Corporation's stock has gained approximately 60.55489% over the past 52 weeks. The 50-day moving average sits at 71.97, while the 200-day moving average is 62.93.
| Beta (5Y) | N/A |
| 52-Week Price Change | 60.55489% |
| 50-Day Moving Average | 71.97 |
| 200-Day Moving Average | 62.93 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Ingevity Corporation generated 1.21B in revenue and converted that into -127.80M in net income, yielding earnings per share of -4.44. EBITDA reached 380.70M, while operating income came in at 276.50M.
| Revenue | 1.21B |
| Gross Profit | 476.00M |
| Operating Income | 276.50M |
| Pretax Income | -155.70M |
| Net Income | -127.80M |
| EBITDA | 380.70M |
| EBIT | 276.50M |
| Earnings Per Share (EPS) | -4.44 |
Ingevity Corporation holds 95.40M in cash and equivalents against 1.24B in total debt, resulting in a net debt position of 1.11B. Total book value stands at 465.10M, with working capital of 172.40M providing operational flexibility.
| Cash & Cash Equivalents | 95.40M |
| Total Debt | 1.24B |
| Net Debt | 1.11B |
| Equity (Book Value) | 465.10M |
| Book Value Per Share | 12.94 |
| Working Capital | 172.40M |
Ingevity Corporation produced 303.80M in operating cash flow over the past twelve months.
| Operating Cash Flow | 303.80M |
| Capital Expenditures | N/A |
| Free Cash Flow | 303.80M |
| FCF Per Share | 8.45 |
Ingevity Corporation operates with a gross margin of 39.30, reflecting its pricing power and cost economics. The operating margin of 22.83 and net profit margin of -10.55 provide insight into operational efficiency.
| Gross Margin | 39.30 |
| Operating Margin | 22.83 |
| Pretax Margin | -12.85 |
| Profit Margin | -10.55 |
| EBITDA Margin | 31.43 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 11.84 |
| FCF Yield | 11.75 |
Ingevity Corporation posts an Altman Z-Score of 2.97, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.97 |